12/11
08:00 am
rnxt
RenovoRx Initiates Patient Enrollment at SCRI Oncology Partners for Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic Cancer
Low
Report
RenovoRx Initiates Patient Enrollment at SCRI Oncology Partners for Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic Cancer
12/10
08:14 am
rnxt
RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET [Yahoo! Finance]
Medium
Report
RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET [Yahoo! Finance]
12/10
08:01 am
rnxt
RenovoRx, Inc. (NASDAQ: RNXT) had its price target raised by analysts at Ascendiant Capital Markets from $8.25 to $9.00. They now have a "buy" rating on the stock.
Medium
Report
RenovoRx, Inc. (NASDAQ: RNXT) had its price target raised by analysts at Ascendiant Capital Markets from $8.25 to $9.00. They now have a "buy" rating on the stock.
12/10
08:00 am
rnxt
RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET
Medium
Report
RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET
12/5
08:10 am
rnxt
RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System [Yahoo! Finance]
Medium
Report
RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System [Yahoo! Finance]
12/5
08:00 am
rnxt
RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System
High
Report
RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System
11/20
08:57 am
rnxt
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial [Yahoo! Finance]
Low
Report
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial [Yahoo! Finance]
11/20
08:45 am
rnxt
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
Medium
Report
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
11/14
08:12 am
rnxt
RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]
Low
Report
RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]
11/14
08:00 am
rnxt
RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights
Low
Report
RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights
9/26
07:46 am
rnxt
We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Medium
Report
We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully [Yahoo! Finance]
9/25
08:30 am
rnxt
RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians
Low
Report
RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians